
A look at some of the year's launches from key manufacturers.

Start your immunization practice here.

Letters, e-mails, posts, and comments from Drug Topics readers

Some OTC products designed to keep those summer adventures fun

New Rx, generics, and OTC

Community pharms discuss competitive options at McKesson's ideaShare.

Researchers plan to study the best way to deploy pharmacy-based naloxone rescue kits to help prevent opioid overdoses and deaths.

The owner of a Los Angeles pharmacy was recently sentenced to 18 months in prison after pleading guilty to charges he participated in a fraud scheme involving the Medicare Part D prescription drug program.

Beginning next year, CVS/Caremark will no longer provide insurance coverage for the erectile dysfunction drug Viagra.

When people are injured by pharmacy mistakes, it is a public safety issue. Where are the state boards of pharmacy?

CVS Health reported a strong second quarter in 2015 with overall net revenue up 7.4% to $37.2 million, compared to the same period last year.

CVS Health is partnering with IBM to document and analyze patient behaviors so that pharmacists and other healthcare professionals can better manage chronic illnesses.

Pharmacists working in healthcare teams were able to better control blood pressure in patients with uncontrolled hypertension, according to a recent study.

Two patients taking the multiple sclerosis drug fingolimod (Gilenya) developed progressive multifocal leukoencephalopathy (PML), a rare and serious brain infection, FDA reported.

Results from the REVERSE-AD prospective cohort study.

FDA issued a drug safety warning that there have been 50 reports of medication errors because of confusion between the antidepressant Brintellix (vortioxetine) and the antiplatelet agent Brilinta (ticagrelor).

Many people are pondering that question following the recent release of statistics from the Drug Enforcement Administration that showed Indiana led the nation in pharmacy robberies.

The Drug Enforcement Administration recently announced plans to hold its 10th National Prescription Drug Take-Back on September 26, 2015.

Pharmacogenomics has the potential to save the U.S. healthcare industry $136 billion in adverse drug events and serve as a profit center for community pharmacies.

That’s the allegation made in a potential class action lawsuit that claims CVS deliberately overcharged some customers for generic drugs by submitting claims to their insurance companies at inflated prices.

The U.S. Court of Appeals for the Federal Circuit in Washington has ruled that Novartis AG’s Sandoz may begin selling the first copy of Amgen Inc.’s Neupogen as soon as Sept. 2.

If you're a pharmacist looking for another route to success, satisfaction, and reward, start here.

While the FDA’s approval of alirocumab (Praluent injection) for high cholesterol is an important new treatment for patients with cardiovascular disease, health plan executives and others are worried about the drug’s price tag.

CVS has agreed to pay $7.4 million to more than 1,600 pharmacists throughout California who claimed the retail giant forced employees to work seven days in a row without paying overtime.

In partnership with the Virginia Department of Health, Walgreens has increased its number of locations to 32 where free HIV testing is offered.

Ohio State University Wexner Medical Center in Columbus, Ohio, is building a $962,000 retail specialty pharmacy, according to Columbus Business First.

The 9th U.S. Circuit Court of Appeals in San Francisco has ruled that Washington can require pharmacies to deliver medications such as Plan B even if owners have a religious objection.

New York State Attorney General Eric Schneiderman recently announced that a Walgreens-owned pharmacy must repay $22.4 million to the state’s Medicaid program for filing false billings.

Diabetes patients taking rosiglitazone or pioglitazone had a 28 percent lower incidence of Parkinson's disease (PD) than people taking other treatments for diabetes who had never taken the glitazone (GTZ) drugs, according to a new study.

When multiple factors are involved, the issues may not be as clear-cut as you think.